Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) EBT Margin (2020 - 2025)

Historic EBT Margin for Relay Therapeutics (RLAY) over the last 6 years, with Q2 2025 value amounting to 10301.62%.

  • Relay Therapeutics' EBT Margin changed N/A to 10301.62% in Q2 2025 from the same period last year, while for Sep 2025 it was 3551.78%, marking a year-over-year decrease of 1017200.0%. This contributed to the annual value of 3374.86% for FY2024, which is 20362700.0% down from last year.
  • As of Q2 2025, Relay Therapeutics' EBT Margin stood at 10301.62%.
  • Relay Therapeutics' EBT Margin's 5-year high stood at 8349600.0% during Q4 2023, with a 5-year trough of 82765.55% in Q2 2023.
  • For the 5-year period, Relay Therapeutics' EBT Margin averaged around 538492.43%, with its median value being 11897.0% (2021).
  • Per our database at Business Quant, Relay Therapeutics' EBT Margin plummeted by 2000000000bps in 2021 and then surged by 2000000000bps in 2023.
  • Over the past 5 years, Relay Therapeutics' EBT Margin (Quarter) stood at 11897.0% in 2021, then tumbled by -124bps to 26671.54% in 2022, then soared by 31405bps to 8349600.0% in 2023, then crashed by -100bps to 813.55% in 2024, then tumbled by -1166bps to 10301.62% in 2025.
  • Its last three reported values are 10301.62% in Q2 2025, 1003.46% for Q1 2025, and 813.55% during Q1 2024.